rHEALTH develops advanced spaceflight diagnostics and health AI solutions for remote monitoring. Their technology enables comprehensive health analysis using portable bioanalyzer systems. This innovation provides significant diagnostic benefits for both space exploration and terrestrial healthcare applications.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional laboratory diagnostics require centralized facilities and trained personnel, creating accessibility barriers and delays in obtaining critical health information. This limitation hinders timely diagnosis, personalized treatment, and proactive health management, particularly in remote or resource-constrained environments.
Solution
rHEALTH develops portable, AI-enhanced diagnostic systems designed to decentralize laboratory testing and provide immediate health insights. Their technology enables individuals and healthcare providers to perform complex biomedical analyses using minimal sample volumes, delivering results within minutes. This approach aims to bridge the gap in healthcare accessibility by bringing advanced diagnostic capabilities directly to the point of need, whether in a clinic, at home, or in challenging environments like space. The integrated AI component offers preliminary interpretation and treatment recommendations, supporting more efficient patient care pathways.
Target Audience
The primary target audience includes healthcare providers, researchers, and individuals seeking accessible, rapid point-of-care diagnostic solutions for personal health monitoring and clinical decision support.
Features
- **rHEALTH ONE Analyzer:** A portable biomedical analyzer utilizing multiple lasers and high-sensitivity photon counting detectors for analyzing microvolumes of biological samples.
- **Dual-Laser Flow Cytometry:** Capable of cell counts and flow cytometry with up to five parameters (3 FL, SSC, FSC) for distinguishing cell types and performing absolute volumetric cell counts.
- **High-Sensitivity Immunoassays:** Supports protein analysis with sensitivity down to picograms per milliliter (pg/mL) using sandwich and competitive immunoassay formats.
- **Multiplexed Biomarker Detection:** Employs nanostrips for massive multiplexing of biomarkers, enabling simultaneous measurement of numerous analytes from a single small sample.
- **Microvolume Sample Analysis:** Requires only 5-10 µL of sample, compatible with various sample types including fingerstick blood and frozen aliquots.
- **SKYE Sensor:** An integrated wearable device for continuous real-time monitoring of vital signs including ECG, heart rate, respiratory rate, SpO2, core temperature, and cuffless blood pressure.
- **Dr. rHEALTH AI:** An artificial intelligence engine that provides optimal treatment and management recommendations based on diagnostic and vital sign data.
- **Spiral Vortex Micromixer:** Patented technology (US Patent 9,194,780) for efficient mixing of small sample volumes within microfluidic channels.
- **Miniaturized Optical Block:** Significantly reduced size and mass optical systems enabling the handheld form factor of the analyzer.